Quick Answer
Scinai Immunotherapeutics Ltd. reported Total Assets of $13.45 million for the year ending 2024.
- Scinai Immunotherapeutics Ltd. showed a decrease of -23.0% in Total Assets from 2023 to 2024.
- This data is from Scinai Immunotherapeutics Ltd.'s annual report (Form 10-K), filed with the SEC on May 7, 2025.
- XBRL data for this metric is available from 2016 to 2024 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: $23.29 million.
- Over the full 9 years of available data (2016 to 2024), Scinai Immunotherapeutics Ltd.'s Total Assets has declined by 55.3%.
- Historical annual values: Fiscal year 2024: $13.45 million | Fiscal year 2023: $17.47 million | Fiscal year 2022: $27.07 million | Fiscal year 2021: $32.04 million | Fiscal year 2020: $56.91 million | Fiscal year 2019: $115.75 million | Fiscal year 2018: $105.84 million | Fiscal year 2017: $81.70 million | Fiscal year 2016: $30.11 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: